Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth
Crissy Dudgeon(Rutgers, The State University of New Jersey), Lin Zhang(Mudanjiang Medical University), P Wang(UPMC Hillman Cancer Center), Anne Sebastiani(University Medical Center of the Johannes Gutenberg University Mainz), Jian Yu(University of Southern California), Rui Yun Peng(Joint Center for Structural Genomics)
Cited by 65
Related Papers
Is a p53-Regulated Inhibitor of G2/M Progression
|Molecular Cell|1997|1.2k
Analysis of human transcriptomes
|Nature Genetics|1999|789
A public database for gene expression in human cancers.
|PubMed|1999|418
Wip1 Phosphatase Modulates ATM-Dependent Signaling Pathways
|Molecular Cell|2006|347